| __timestamp | Axsome Therapeutics, Inc. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4279200 | 2704597 |
| Thursday, January 1, 2015 | 6776987 | 15470000 |
| Friday, January 1, 2016 | 21199860 | 28037000 |
| Sunday, January 1, 2017 | 19957616 | 71615000 |
| Monday, January 1, 2018 | 23495055 | 99828000 |
| Tuesday, January 1, 2019 | 53647067 | 166023000 |
| Wednesday, January 1, 2020 | 70244579 | 201727000 |
| Friday, January 1, 2021 | 58060725 | 259039000 |
| Saturday, January 1, 2022 | 57947447 | 294781000 |
| Sunday, January 1, 2023 | 97944000 | 344077000 |
| Monday, January 1, 2024 | 187077000 |
In pursuit of knowledge
In the competitive world of biotechnology, innovation is the lifeblood of progress. Over the past decade, Axsome Therapeutics, Inc. and Iovance Biotherapeutics, Inc. have demonstrated a steadfast commitment to research and development (R&D). Since 2014, Iovance has consistently outpaced Axsome in R&D spending, with a staggering 1,172% increase by 2023. In contrast, Axsome's R&D expenses grew by approximately 2,188% over the same period. This significant investment underscores the companies' dedication to pioneering new therapies and treatments. Notably, in 2023, Iovance's R&D expenses reached a peak, nearly 3.5 times higher than Axsome's. These figures highlight the strategic emphasis both companies place on innovation, a critical driver of their long-term success. As the biotech landscape evolves, such investments are pivotal in maintaining a competitive edge and delivering groundbreaking solutions to unmet medical needs.
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Axsome Therapeutics, Inc.
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.
R&D Spending Showdown: United Therapeutics Corporation vs Axsome Therapeutics, Inc.
Comparing Innovation Spending: Incyte Corporation and Iovance Biotherapeutics, Inc.
Dr. Reddy's Laboratories Limited or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Sarepta Therapeutics, Inc. vs Axsome Therapeutics, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.
Axsome Therapeutics, Inc. or BioCryst Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Axsome Therapeutics, Inc. vs Xencor, Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Novavax, Inc.
Mesoblast Limited or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Geron Corporation or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?